// App-Quantinova.ai

S261 : SAFETY AND PRELIMINARY EFFICACY FINDINGS OF AUTO4, A TRBC1-TARGETTING CAR, IN RELAPSED/REFRACTORY TRBC1 POSITIVE SELECTED T CELL NON-HODGKIN LYMPHOMA

Researchers

Presenter

  • Kate Cwynarski

Principal Investigators

  • Eleni Tholouli

  • Gloria Iacoboni

  • Tobias Menne

  • David Irvine

  • Leigh Wood

  • Michael Zhang

  • Kevin Duffy

  • Birgit Huber

  • Wolfram Brugger

  • Martin Pule

Medical Centers

  • Manchester Royal Infirmary,Manchester ,Reino Unido

  • Autolus Therapeutics,Munich,Allemagne

  • Autolus Therapeutics,London,Verenigd Koninkrijk

  • Cancer Clinial Trials Unit,University College London,London,Vereinigtes Königreich

  • Autolus Therapeutics,Munich,Германия

  • University of Glasgow,Glasgow,Royaume-uni

  • Cancer Clinial Trials Unit

  • Academic Neonatology, University College London, London, United Kingdom

  • Autolus Therapeutics,Munich,Deutschland

  • Haematology,University College London,London,Royaume-uni

  • Autolus Therapeutics,Munich,Allemagne

  • Development,Autolus Therapeutics,London,Vereinigtes Königreich

  • University of Glasgow, Glasgow, United Kingdom

  • Infections Group, MRC Clinical Trials Unit at University College London, London, United Kingdom

  • Development,Autolus Therapeutics,London,Vereinigtes Königreich

  • Cancer Clinical Trials Unit,University College London

  • Research Dept. Pathology,University College London,London,Vereinigtes Königreich

  • Vall d´Hebron Hospital Campus, Barcelona, Spain

  • Autolus Therapeutics,Rockville,Verenigde Staten

  • Freeman Hospital Newcastle,Newcastl

  • Autolus Therapeutics,Rockville,Verenigde Staten

  • Freeman Hospital Newcastle,Newcastle,Reino Unido

  • Autolus Therapeutics,Rockville,Verenigde Staten

  • University of Glasgow,Glasgow,Vereinigtes Königreich

  • Manchester Royal Infirmary,Manchester ,Reino Unido

  • Manchester Royal Infirmary, Manchester, United Kingdom

  • Clinical Dev

  • Hematology,Imperial College of London,London,Verenigd Koninkrijk

  • Dept. Imaging,University College London Hospitals,London,Regno Unito

  • VHIO Vall d'Hebron Hospital,Barcelona,España

  • VHIO Vall d'Hebron Hospital,Barcelona,España

  • University of Glasgow,Glasgow,Regno Unito

  • VHIO Vall d'Hebron Hospital,Barcelona,España

  • EScience, University of Glasgow, Glasgow, UK

  • VHIO Vall d'Hebron Hospital,Barcelona,España

  • Freeman Hospital Newcastle,Newcastle,Reino Unido

  • Freeman Hosp, Newcastle, Newcastle, United Kingdom

  • University College London,London,Reino Unido

  • Autolus Therapeutics, London, NJ, United Kingdom

  • Leicester Royal Infirmary,Leicester,Vereinigtes Königreich

  • Autolus Therapeutics,Munich,Allemagne

  • Rheumatology, University College London

  • Autolus Therapeutics,London,Storbritannien

  • Development,Autolus Therapeutics,London,Vereinigtes Königreich

  • Autolus Therapeutics,Rockville,Stati Uniti

  • VHIO Vall d'Hebron Hospital,Barcelona,España

  • Development,Autolus Therapeutics,London,Vereinigtes Königreich

  • University of Glasgow,Glasgow,Соединённое Королевство

  • Autolus Therapeutics,Rockville,Stati Uniti

  • Leicester Royal Infirmary,Leicester,Vereinigtes Königreich

  • Autolus Therapeutics,Munich,Allemagne

  • Freeman Hospital Newcastle,Newcastle,Royaume-uni

  • Freeman Hospital Newcastle,Newcastle,Verenigd Koninkrijk

  • Autolus Therapeutics,Munich,Deutschland

  • VHIO Vall d'Hebron Hospital,Barcelona,España

  • Autolus Therapeutics,Rockville,USA

  • Freeman Hospital Newcastle,Newcastle,Verenigd Koninkrijk

  • VHIO Vall d'Hebron Hospital,Barcelona,España

  • Autolus Therapeutics,Munich,Deutschland

  • Manchester Royal Infirmary,Manchester ,Royaume-uni

  • VHIO Vall d'Hebron Hospital,Barcelona,España

  • University of Glasgow,Glasgow,Regno Unito

  • Research &amp

  • Development,

  • Autolus Therapeutics,Munich,Allemagne

  • Manchester Royal Infirmary

  • University of Glasgow,Glasgow,Verenigd Koninkrijk

  • UCL Cancer Trials Centre,University College London,London,Royaume-uni

  • Autolus Therapeutics,Rockville,Estados Unidos

  • Autolus Therapeutics,London,Соединённое Королевство

Locations

  • United Kingdom

  • United States

  • Venezuela

  • Spain

  • South Africa

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non-Hodgkin's Lymphoma

  • Peripheral T-cell lymphoma

Biomarkers

  • Coxsackie Virus And Adenovirus Receptor

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • fludarabine tablet

Outcome

  • N/A

Study Design

  • Single Arm

  • Multicenteric

  • Dose Escalation

  • Cohort

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved